The Holding of Pharmaceutical SOEs with Bio Farma as the holding parent with members Kimia Farma, Indofarma, and Inuki celebrated its 3rd anniversary. The event was also filled with the inauguration of the Pharmaceutical SOE Holding named Biofarma Group and the launching of Bio Farma’s two newest products, CerviScan and Medbiz.
Indonesian Minister of Health, Budi Gunadi Sadikin expressed his pride in transforming the Pharmaceutical SOE Holding. “In the past three years, I have seen the achievements of the Pharmaceutical BUMN Holding increasing, and of course, this is a matter of pride. However, I challenge Bio Farma always to increase its profit and continue to innovate in creating new products the community needs,” said Budi Gunadi Sadikin.
“The ultimate goal of the existence of the Pharmaceutical SOE Holding is straightforward, namely only three letters (3A), the first is Availability, which is how the people of Indonesia can enjoy all pharmaceutical health products and services; the second is Accessibility, how easy it is for products to be enjoyed, and the third is Affordability where the price can be reached,” said Honesti Basyir, Director of the Pharmaceutical SOE Holding.
